Phibro Animal Health (PAHC) Gross Profit (2012 - 2026)

Phibro Animal Health has reported Gross Profit for 15 years, with the latest figure at $134.4 million in Q2 2026.

• On a quarterly basis, Gross Profit rose 22.17% year-over-year to $134.4 million in Q2 2026; TTM through Jun 2026 was $512.5 million, a 28.15% increase from a year earlier, with the FY2026 full-year figure at $512.5 million, up 28.15% from the prior year.
• Gross Profit was $134.4 million for Q2 2026 at Phibro Animal Health, up from $125.7 million in the prior quarter.
• The five-year high for Gross Profit was $134.4 million in Q2 2026, with the low at $67.7 million in Q3 2023.
• Average Gross Profit over 5 years is $93.0 million, with a median of $81.5 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2025: Gross Profit retreated 2.24% in 2023, then soared 43.46% in 2025.
• Over 5 years, Gross Profit stood at $77.4 million in 2022, then increased by 1.59% to $78.6 million in 2023, then rose by 29.58% to $101.9 million in 2024, then soared by 30.22% to $132.7 million in 2025, then rose by 1.32% to $134.4 million in 2026.
• The last three Gross Profit figures came in at $134.4 million (Q2 2026), $125.7 million (Q1 2026), and $132.7 million (Q4 2025), per Business Quant data.